Skip to main content
. 2015 Mar 17;29(2):115–120. doi: 10.3341/kjo.2015.29.2.115

Table 2. Clinical efficacy after botulinum neurotoxin type A individualized injection according to spasm-dominant site.

graphic file with name kjo-29-115-i002.jpg

ODG = orbicularis-dominant group; CDG = corrugator-dominant group; PDG = palpebral part of the orbicularis-dominant group; FDS = functional disability score.

*Kruskal-Wallis test.